; (ii) the degree to which the strategy increases assistance to and activities by the United States in target countries; (iii) the use of programs, projects, or activities to develop and scale-up new technologies and approaches, including those identified by public-private partnerships for research and innovation, and the degree to which such programs, projects, or activities are posed to go to scale; and (iv) the methods used to leverage innovative financing and other public and private resources and the progress made by such methods. (D) A description of how each program, project, or activity implementing the strategy is designed to— (i) reach underserved, marginalized, vulnerable, or impoverished populations; (ii) address the causes of newborn, infant, child, and maternal morbidity and mortality, including pre-term births, with innovative efforts and interventions; (iii) invest in programs, projects, or activities that empower women, support voluntarism, and provide quality, respectful, evidence-based maternity care; (iv) improve transparency and accountability at all levels and include common metrics for tracking progress in achieving the objectives of the strategy; (v) ensure that high-impact, evidence-based interventions are prioritized, including interventions promoting healthy pregnancies; and (vi) expand access to quality services for healthcare workers and for communities in target countries and include measures of accountability to such communities. (E) A comprehensive list of grants, contracts, and cooperative agreements awarded to implement the strategy, that includes— (i) a description of the targets for coverage of interventions or services supported by such grants, contracts, or cooperative agreements, the baseline against which they are measured, and the status of their progress in meeting the targets